Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics. https://t.co/4k1W02xVDa
RT @HLIStPauls: HLI Principal Investigator Dr. Bradley Quon is the senior author on this new publication in @SciReports. Read more about ho…
HLI Principal Investigator Dr. Bradley Quon is the senior author on this new publication in @SciReports. Read more about how the team is using quantitative proteomics to identify biomarkers for #CysticFibrosis. https://t.co/vP6QNeduMc
RT @ubcmsl: In a new study in @SciReports, Dr. Bradley Quon, in collaboration with @lenjf, identifies proteins upregulated following #antib…
In a new study in @SciReports, Dr. Bradley Quon, in collaboration with @lenjf, identifies proteins upregulated following #antibiotics treatment that could potentially contribute to sustained lung impairment in #CysticFibrosis patients. https://t.co/M0tVGvd
Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics https://t.co/spyms1wBJY
Identification of novel #blood #biomarkers of treatment response in #cystic #fibrosis #pulmonary #exacerbations by label-free quantitative #proteomics. #CF #Lung #PEx https://t.co/ZQ79DBifr7 https://t.co/axiwOl6PyR
RT @realBioMassSpec: Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-fre…
Identification of novel blood biomarkers of treatment response in cystic fibrosis pulmonary exacerbations by label-free quantitative proteomics #SciRep #MassSpec https://t.co/qjGvYEI8QQ